Cancer Research Prevention Award  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawano, K.
Right arrow Articles by Ioannides, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawano, K.
Right arrow Articles by Ioannides, C. G.
[Cancer Research 65, 2930-2937, April 1, 2005]
© 2005 American Association for Cancer Research


Immunology

Sensitivity of Undifferentiated, High-TCR Density CD8+ Cells to Methylene Groups Appended to Tumor Antigen Determines Their Differentiation or Death

Kouichiro Kawano1, Clay L. Efferson1, George E. Peoples4, Darrick Carter5, Naotake Tsuda1, James L. Murray2 and Constantin G. Ioannides1,3

Departments of 1 Gynecologic Oncology, 2 Breast Medical Oncology, and 3 Immunology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; 4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland; and 5 Infectious Disease Research Institute, Seattle, Washington

Requests for reprints: Constantin G. Ioannides, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Unit 440, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-2849; Fax: 713-792-3575; E-mail: cioannid{at}mdanderson.org.

CD8+ cells expressing high numbers of TCR per cell (TCRhi) are considered important mediators of antitumor effects. To understand the relationship between TCR density and antigen affinity for TCR in the outcome of stimulation with antigen and differentiation of CTL recognizing tumor antigen, we analyzed perforin induction in ovarian tumor-associated lymphocytes in response to the smallest possible changes in the atomic forces of interaction between antigen and TCR. Stimulating undifferentiated, apoptosis-resistant CD8+ cells expressing high levels of E75-TCR (TCRhi) with variants of the CTL epitope E75, HER-2 (369-377), induced their stepwise differentiation, first to IFN-{gamma}+ Perf and to TCRhi IFN-{gamma}+ Perf+ cells. Blocking caspase-9 activation at antigen stimulation also enhanced the generation of TCRhi Perfhi cells, demonstrating that TCR density dictated the pathway of death activated by stimulation with the same agonist. Expansion and differentiation of TCRhi Perf+ CTL required an agonist of optimal CH2 side chain length, which in this study was equal to two CH2 groups appended to E75 at the Gly4 position. Side chains one CH2 shorter or longer than optimal were either less stimulatory or induced death of TCRhi Perf+ cells. Differentiation of TCRhi CD8+ cells can be finely tuned by synthetic amino acids in the peptide, whose side chains induce small increments in the affinity of the antigen for TCR below the affinity which induce apoptosis.

Key Words: CTL • perforin • TCR • synthetic amino acids • HER-2




This article has been cited by other articles:


Home page
Anticancer ResHome page
Y. LI, S. MATSUEDA, C. L. EFFERSON, N. TSUDA, K. KAWANO, H. GAO, G. E. PEOPLES, and C. G. IOANNIDES
Distinct Patient Responses to Activation of T-cells by Free HER-2, G89 (777-789) and Protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} Peptides Could Lead to Development of Personalized Cancer Vaccines
Anticancer Res, January 1, 2009; 29(1): 41 - 58.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Tsuda, D. Z. Chang, T. Mine, C. Efferson, A. Garcia-Sastre, X. Wang, S. Ferrone, and C. G. Ioannides
Taxol Increases the Amount and T Cell Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
Cancer Res., September 1, 2007; 67(17): 8378 - 8387.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.